In attempts to improve tumor targeting, IgG binding domains of protein A were engineered into the SIN E2 envelope protein, which enhanced substantially transduction of host cells treated with a monoclonal antibody against surface proteins [33]. Here, ERVW-1 is linked to neoplasm.